Human B-type natriuretic peptide is not degraded by meprin A
- 1 October 2010
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 80 (7) , 1007-1011
Abstract
No abstract availableKeywords
Funding Information
- The American Heart Association (Grant 0950053G)
- the National Institutes of Health (Grant R21HL093402)
This publication has 18 references indexed in Scilit:
- A Familial Mutation Renders Atrial Natriuretic Peptide Resistant to Proteolytic DegradationJournal of Biological Chemistry, 2009
- B-type natriuretic peptide 8-32, which is produced from mature BNP 1-32 by the metalloprotease meprin A, has reduced bioactivityAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Novel Bifunctional Natriuretic Peptides as Potential TherapeuticsJournal of Biological Chemistry, 2008
- Meprins, membrane-bound and secreted astacin metalloproteinasesMolecular Aspects of Medicine, 2008
- Successive Action of Meprin A and Neprilysin Catabolizes B-Type Natriuretic PeptideCirculation Research, 2007
- Biochemical analysis of neutral endopeptidase activity reveals independent catabolism of atrial and brain natriuretic peptideBiological Chemistry, 2004
- Degradation of brain natriuretic peptide by neutral endopeptidase: Species specific sites of proteolysis determined by mass spectrometryBiochemical and Biophysical Research Communications, 1991
- Degradation of porcine brain natriuretic peptide (pBNP-26) by endoprotease-24.11 from kidney cortical membranesBiochemical and Biophysical Research Communications, 1989
- Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion.Journal of Clinical Investigation, 1986
- Rat atrial natriuretic factor: Isolation, structure and biological activities of four major peptidesBiochemical and Biophysical Research Communications, 1984